Merck (MRK) Q1 2024 Earnings Call Transcript : vimarsana.com

MRK earnings call for the period ending March 31, 2024.

Related Keywords

Japan , United States , China , Chicago , Illinois , Argentina , Argentine , American , America , Luisa Hector Berenberg , Daiichi Sankyo Adcs , Seamus Fernandez , Asia Pacific , James Shin , Louise Chen , Louise Chen Cantor Fitzgerald , Evan Seigerman , Peter Dannenbaum , Rob Davis , Daina Graybosch Leerink , Chris Schott Jpmorgan , Tim Anderson , Carter Gould Barclays , Luisa Hector , Chris Shibutani Goldman Sachs , Terence Flynn , Terence Flynn Morgan Stanley , Seamus Fernandez Guggenheim , Chris Schott , Daiichi Sankyo , Caroline Litchfield , Evan Siegerman , Carter Gould , Chris Shibutani , Trung Huynh , Daina Graybosch , Tim Anderson Wolfe Research Analyst , Centers Of Excellence , Deutsche Bank , Our Human Health , Urogen Congress , Institute Butantan , Morgan Stanley , James Shin Deutsche Bank Analyst , Barclays , Animal Health , International Agency For Research On Cancer , Company Analyst , Merck Co , European Commission , Merck Research Labs , International Society Of Pneumonia , Nvidia , Advisory Committee On Immunization Practices , American Cancer Society , Goldman Sachs , Wolfe Research , Zenith , European Medicines Agency , Vice President , Merck Research , Motley Fool Stock Advisor , Stock Advisorservice , Stock Advisor , Securities Litigation Reform Act , Chief Executive , Wind River , Human Health , Light Spark , Harpoon Therapeutics , International Society , Pneumococcal Diseases , Immunization Practices , International Agency , Sub Saharan Africa , South America , Southeast Asia , Umer Raffat , American Cancer , Capital Markets , Leerink Partners , Cantor Fitzgerald , Berenberg Capital Markets , Senior Vice President , Chief Executive Officer , Merck , Business Development ,